A statement of changes in beneficial ownership was filed on September 15, 2026, disclosing that Paul A. Keel, a director of The Cooper Companies, Inc., purchased 4,701.015 shares of common stock on September 11, 2026.
Key Highlights
- Reporting person: Paul A. Keel, identified as a Director of The Cooper Companies, Inc.
- Transaction: Purchase (transaction code P) of 4,701.015 shares of common stock on September 11, 2026.
- Price: Weighted average price of $53.18 per share, with individual transactions ranging from $53.165 to $53.18.
- Resulting ownership: 4,701.015 shares of common stock beneficially owned directly following the transaction.
- Filing signed: Paul Keel by Greta Kolcon, as Attorney-in-Fact, dated September 15, 2026.
Director Purchase Details for The Cooper Companies
According to the filing, Paul A. Keel, a director of The Cooper Companies, Inc. (NASDAQ:COO), acquired 4,701.015 shares of common stock on September 11, 2026. The shares are listed as directly owned and were acquired through an open-market purchase, as indicated by transaction code P in the filing. The Cooper Companies is a medical device company whose products include contact lenses and fertility-related medical devices, operating through its CooperVision and CooperSurgical business segments.
The filing notes that the reported price of $53.18 is a weighted average, reflecting multiple transactions executed at prices ranging from $53.165 to $53.18. According to the filing, the reporting person "undertakes to provide The Cooper Companies, Inc., any security holder of The Cooper Companies, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range." Following the reported transaction, Keel's total direct beneficial ownership stands at 4,701.015 shares, as disclosed in Table I of the filing. No derivative securities transactions were reported in Table II.
What Was Disclosed
The filing disclosed a director-level open-market purchase of 4,701.015 shares of Cooper Companies common stock at a weighted average price of $53.18 on September 11, 2026, resulting in direct beneficial ownership of 4,701.015 shares.






Please wait processing your request...